Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Males and non-pregnant, non-lactating females 18 years or older with a BMI of 18-40 kg/m2 inclusive.~* Regarding renal function, subjects will be classified as either normal or as suffering from mild,moderate or severe renal impairment. Classification of renal impairment will be estimated by the MDRD and Cockcroft-Gault formulae~Exclusion Criteria:~* Any disease, condition and/or chronic medications which might compromise the hematologic, cardiovascular, pulmonary renal, gastrointestinal, hepatic, or central nervous system; or other conditions that might interfere with the distribution, metabolism or excretion of study drug, or would place the subject at increased risk~* Evidence of significant respiratory, gastrointestinal or hepatic disease at screening~* Positive screen for hepatitis B surface antigen, or HIV~* Positive test in drugs of abuse screens or alcohol on admission to the clinic

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Subjects with mild renal impairment (Type: EXPERIMENTAL): None
- Subjects with moderate renal impairment (Type: EXPERIMENTAL): None
- Subjects with normal renal function (Type: EXPERIMENTAL): None
- Subjects with severe renal impairment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).